Research
About the Research Team
Why Research Matters
Evidence-based research allows clients, policymakers, the healthcare community, and the general public to make clinically and financially-sound decisions about the pharmacy benefit. The best-in-class Research department at Express Scripts provides timely, relevant, and objective documentation of better health and value to support decisions about the pharmacy benefit.
Steve Miller, MD, Senior Vice President & Chief Medical Officer, Research & Clinical Sciences
Dr. Steve Miller joined Express Scripts in 2005. An international speaker and author of more than 80 scientific articles, Dr. Miller is recognized for his research in the areas of acute renal failure, transplantation, hypertension and healthcare economics. Dr. Miller has been actively involved in the development of Express Scripts clinical programs supporting the use of generic pharmaceuticals and specialty medications. He serves as a leader in the promotion of legislation to create a pathway at the FDA for regulation of biogenerics and biosimilars.
Dr. Miller earned his medical degree from the University of Missouri-Kansas City. He received additional training in the Pathology and Research Fellowship at the University of Alabama at Birmingham and in cardiology at the University of California, San Francisco. In addition to his medical education, Dr. Miller earned his MBA at the Olin School of Business at Washington University in St. Louis.
Emily Cox, RPh, PhD, Senior Director, Research
Dr. Emily Cox joined Express Scripts in 2000. She brings over 20 years of experience in pharmacy practice and health services research with a focus on assessing the clinical and financial realities of prescription drug use within the pharmacy benefit. With over 70 peer-reviewed publications and conference abstracts to her credit, her research has been featured in the New York Times, USA Today, the Wall Street Journal and on National Public Radio.
Dr. Cox has participated in the development of national standards including serving as a member of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Task Force on Good Research Practices for Retrospective Database Studies, serving as a Steering Committee member of The National Quality Forum (NQF) National Voluntary Consensus Standards for Medication Management and the Pharmacy Quality Alliance (PQA). Dr. Cox holds a Bachelor of Science in Pharmacy degree from the University of Pittsburgh and a Doctor of Philosophy degree concentrating in Health Economics from the University of South Carolina. Prior to joining Express Scripts, Dr. Cox was a faculty member of the University of Arizona Colleges of Pharmacy and Medicine.
Scott Devine, BPharm, MPH, PhD, Director, Health Services Research
Dr. Scott Devine has been involved in the delivery of healthcare and healthcare research for over 15 years. He holds a Bachelor of Science in Pharmacy degree from the University of Houston School of Pharmacy, a Master of Public Health degree from the Columbia University Mailman School of Public Health, and a Doctor of Philosophy degree in Epidemiology from University of North Carolina School of Public Health.
Dr. Devine has worked as a hospital, retail and long-term care pharmacist, and most recently as a Regional Outcomes Research Scientist for Pfizer. Prior to his work at Pfizer, he completed a post-doctoral fellowship with the US Food and Drug Administration’s Office of Safety and Evaluation. Scott’s research interests include the methodologies for creating complex and informative disease definitions through using automated healthcare databases, peri-natal epidemiology, propensity score modeling, implementation of survival analysis techniques and the use of large automated healthcare databases for drug evaluation and pharmacovigilance research.
Expert Resources